Applied DNA to initiate clinical trial of Covid-19 vaccine for cats [Reuters]
Applied DNA Sciences, Inc. (APDN)
Last applied dna sciences, inc. earnings: 8/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adnas.com/molecular-based-security/investors
Company Research
Source: Reuters
Applied DNA to initiate clinical trial of Covid-19 vaccine for cats By Reuters Staff 1 Min Read Sept 16 (Reuters) - Applied DNA Sciences plans to initiate clinical trial of one of its five LineaDNA vaccine candidates for veterinary use to prevent coronavirus infections in domestic cats, the diagnostic test maker said on Wednesday. The trials will be conducted in collaboration with biotechnology firm Evvivax S.R.L. on receiving approval from the U.S. Department of Agriculture, Applied DNA said in a statement. The study will evaluate domestic feline immune response, safety and tolerability of the vaccine candidate and determine evidence of antibody and T-cell response in them. The trial intends to enroll 30 healthy domestic felines and follow them for six months. Earlier in July, Applied DNA said five of its LineaDNA vaccine candidates showed strong antibody responses at low doses in mice studies. (Reporting by Aishwarya Nair in Bengaluru; Editing by Anil D’Silva)
Show less
Read more
Impact Snapshot
Event Time:
APDN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
APDN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
APDN alerts
High impacting Applied DNA Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
APDN
News
- Applied DNA Sciences, Inc. (NASDAQ: APDN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Applied DNA Sciences, Inc. (NASDAQ: APDN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Applied DNA Sciences, Inc. (NASDAQ: APDN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Applied DNA Sciences, Inc. (NASDAQ: APDN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start [Yahoo! Finance]Yahoo! Finance
APDN
Earnings
- 2/8/24 - Beat
APDN
Sec Filings
- 4/19/24 - Form 8-K
- 4/16/24 - Form 8-K
- 3/21/24 - Form EFFECT
- APDN's page on the SEC website